Who Exports Clindamycin from India — 527 Suppliers Behind a $90.2M Market
India's clindamycin export market is supplied by 527 active exporters who collectively shipped $90.2M across 7,242 shipments. ENCUBE ETHICALS PRIVATE LIMITED leads with a 19.6% market share, followed by AUROBINDO PHARMA LTD and MICRO LABS LIMITED. The top 5 suppliers together control 55.6% of total export value, reflecting a moderately competitive market structure.
Top Clindamycin Exporters from India — Ranked by Export Value
ENCUBE ETHICALS PRIVATE LIMITED is the leading clindamycin exporter from India, holding a 19.6% share of the $90.2M market across 7,242 shipments from 527 exporters. The top 5 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, GLENMARK PHARMACEUTICALS LIMITED — collectively control 55.6% of total export value, indicating a moderately concentrated market. Individual shares are: ENCUBE ETHICALS PRIVATE LIMITED (19.6%), AUROBINDO PHARMA LTD (16.1%), MICRO LABS LIMITED (7.7%), AUROBINDO PHARMA LIMITED (7.0%), GLENMARK PHARMACEUTICALS LIMITED (5.2%).
Top Clindamycin Exporters from India
Ranked by export value · 527 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $17.7M | 6 | 19.6% |
| 2 | AUROBINDO PHARMA LTD CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $14.6M | 2 | 16.1% |
| 3 | MICRO LABS LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $6.9M | 4 | 7.7% |
| 4 | AUROBINDO PHARMA LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $6.3M | 2 | 7.0% |
| 5 | GLENMARK PHARMACEUTICALS LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $4.7M | 6 | 5.2% |
| 6 | BIOMATRIX HEALTHCARE PRIVATE LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 3CLINDAMYCIN, CLOTRIMAZOLE & METRONIDAZOLCLINDAMYCIN & CLOTRIMAZILE VAGINAL CAPSU | $3.6M | 6 | 4.0% |
| 7 | MULTICO EXPORTS PRIVATE LIMITED CLINDAMYCIN PHOSPHATE GEL USP 1% W/W (CLINDAMYCIN PHOSPHATE GEL USP ? 1% W/WCLINDAMYCIN PHOSPHATE GEL USP ? 1% W/W ( | $3.1M | 2 | 3.4% |
| 8 | MYLAN LABORATORIES LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $2.9M | 2 | 3.2% |
| 9 | THE MADRAS PHARMACEUTICAL BERGCLIN 300 (CLINDAMYCIN CAPSULES BP 30PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-150CLINDAMYCIN 300 MG TABLET B.NO.KE 14 202 | $2.7M | 3 | 3.0% |
| 10 | ZYDUS LIFESCIENCES LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $2.3M | 1 | 2.6% |
| 11 | VIVIMED LIFE SCIENCES PRIVATE LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SNOSCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG 100'SCLINDAMYCIN HYDROCHLORIDE CAPSULES 300MG100'S | $1.7M | 1 | 1.9% |
| 12 | ATOZ PHARMACEUTICALS PRIVATE LIMITED BERGCLIN 300 (CLINDAMYCIN CAPSULES BP 30CLINDAMYCIN 300 MG TABLET B.NO.KE 14 202CLINDAMYCIN 300 MG TABLET B.NO.KE 14 201 | $1.2M | 1 | 1.4% |
| 13 | MEDREICH LIMITED CLINDAMYCIN HYDROCHLORIDE CAPSULES 300MGCLINDAMYCIN 300MG HARD CAPSULESCLINDAMYCIN PHOSPHATE GEL USP 1% | $1.1M | 2 | 1.2% |
| 14 | VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED CLINDAMYCIN 10MG/G + BENZOYL PEROXIDE 50MG/G GEL 30GCLINDAMYCIN HCL 150MG HARD CAPSULES 2X12SCLINDAMYCIN CAPSULES 150MG | $955.0K | 1 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Clindamycin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Approved | Yes (September 2023) | Yes (April 2024 | Not verified | Received WHO-GMP approval for Unit IV in September 2023 and EU GMP certification |
| Glenmark Pharmaceuticals Limited | Approved | Yes | Yes | Not verified | Holds FDA approval, WHO-GMP, and EU GMP certifications. |
| Micro Labs Limited | Approved | Yes | Yes | Not verified | Certified by FDA, WHO-GMP, and EU GMP. |
| Mylan Laboratories Limited | Approved | Yes | Yes | Not verified | Maintains FDA approval, WHO-GMP, and EU GMP certifications. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Not verified | Holds FDA approval, WHO-GMP, and EU GMP certifications. |
| The Madras Pharmaceuticals | Approved | Yes | Yes | Not verified | Certified by FDA, WHO-GMP, and EU GMP. |
| Medreich Limited | Approved | Yes | Yes | Not verified | Maintains FDA approval, WHO-GMP, and EU GMP certifications. |
| Vergo Pharma Research Laboratories Private Limited | Approved | Yes | Yes | Not verified | Holds FDA approval, WHO-GMP, and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 8 leading Clindamycin exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Clindamycin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is supported by the presence of major pharmaceutical companies such as Aurobindo Pharma Ltd., which has reported Clindamycin exports totaling $14.6 million, accounting for 16.1% of the market share. The city's robust infrastructure and skilled workforce make it a pivotal hub for active pharmaceutical ingredient (API) manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, hosts Alembic Pharmaceuticals, a company with a significant presence in the production of various formulations. The region's emphasis on finished dosage forms complements the bulk drug production capabilities of other clusters, contributing to a comprehensive pharmaceutical manufacturing ecosystem.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Companies like Glenmark Pharmaceuticals Limited, headquartered in Mumbai, have reported Clindamycin exports amounting to $4.7 million, representing 5.2% of the market share. The region's well-established port facilities and logistical advantages facilitate efficient international distribution, reinforcing its role in global pharmaceutical trade.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. This area attracts numerous pharmaceutical companies seeking cost-effective production solutions, thereby enhancing India's overall manufacturing capacity.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Regional Specializations: Source bulk drugs from Hyderabad for cost-effective APIs and formulations from Ahmedabad-Vadodara to ensure high-quality finished products.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure for efficient international shipping and distribution.
- Evaluate Cost Benefits: Consider the Baddi-Nalagarh zone for manufacturing to take advantage of tax incentives and reduce production costs.
By strategically sourcing from these specialized clusters, companies can enhance their supply chain resilience and capitalize on India's diverse pharmaceutical manufacturing capabilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Clindamycin exporters from India
Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences
In July 2024, Glenmark Pharmaceuticals Limited completed the divestment of a 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma Limited for approximately ₹5,651 crore. This strategic move aimed to reduce debt and refocus on Glenmark's core innovative pipeline. - IMPACT: This divestment may lead to a reallocation of resources within Glenmark, potentially affecting its Clindamycin production and export strategies.
Impact: This divestment may lead to a reallocation of resources within Glenmark, potentially affecting its Clindamycin production and export strategies.
Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing
In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma Limited, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: While this collaboration focuses on biologics, it may influence Aurobindo's overall manufacturing capacity and resource allocation, potentially impacting Clindamycin production and exports.
Impact: While this collaboration focuses on biologics, it may influence Aurobindo's overall manufacturing capacity and resource allocation, potentially impacting Clindamycin production and exports.
Glenmark Pharmaceuticals Limited — Glenmark transfers consumer care business to new subsidiary
In August 2025, Glenmark Pharmaceuticals announced the transfer of its consumer care business into a newly incorporated, wholly owned subsidiary named Glenmark Consumer Care Limited. This restructuring aims to segregate the marketing and trading of pharmaceutical and consumer care products. - IMPACT: This corporate restructuring may lead to a more focused approach in Glenmark's pharmaceutical operations, potentially affecting its Clindamycin export strategies.
Impact: This corporate restructuring may lead to a more focused approach in Glenmark's pharmaceutical operations, potentially affecting its Clindamycin export strategies.
Common Questions — Clindamycin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which clindamycin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ENCUBE ETHICALS PRIVATE LIMITED leads with 291 recorded shipments worth $17.7M. AUROBINDO PHARMA LTD (188 shipments) and MICRO LABS LIMITED (93 shipments) are also established high-volume exporters.
Q How many clindamycin manufacturers are there in India?
India has 527 active clindamycin exporters with a combined export market of $90.2M across 7,242 shipments to 144 countries. The top 5 suppliers hold 55.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for clindamycin from India?
Average FOB unit price: $4.78 per unit, ranging from $0.01 to $1003.67. Average shipment value: $12.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 527 verified Indian exporters of Clindamycin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 7,242 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 144 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,242 Verified Shipments
527 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists